Skip to main content

Published locations for Benralizumab maintains effectiveness in severe asthma at 2 years

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Benralizumab maintains effectiveness in severe asthma at 2 years

User login

  • Reset your password
  • /content/benralizumab-maintains-effectiveness-severe-asthma-2-years
  • /clinicianreviews/article/192477/asthma/benralizumab-maintains-effectiveness-severe-asthma-2-years
  • /pediatricnews/article/192477/asthma/benralizumab-maintains-effectiveness-severe-asthma-2-years
  • /pulmonary-health-hub/article/192477/asthma/benralizumab-maintains-effectiveness-severe-asthma-2
  • /pediatrics/article/192477/asthma/benralizumab-maintains-effectiveness-severe-asthma-2-years
  • /internalmedicine/article/192477/asthma/benralizumab-maintains-effectiveness-severe-asthma-2-years
  • /familymedicine/article/192477/asthma/benralizumab-maintains-effectiveness-severe-asthma-2-years
  • /chestphysician/article/192477/asthma/benralizumab-maintains-effectiveness-severe-asthma-2-years